Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin Lee Freeman currently holds 358,686 shares of Health Catalyst, Inc. (HCAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Lee Freeman has been a net seller of HCAT stock. They have purchased $0 and sold $103.1K worth of shares.
Kevin Lee Freeman's most recent insider trade was on Dec 1, 2025, when they sold 16,401 shares at $2.90 per share.
Kevin Lee Freeman serves as Executive at Health Catalyst, Inc. (HCAT). They have executed 17 insider transactions totaling $103.1K over their tenure at the company.
Kevin Lee Freeman holds the position of Executive at Health Catalyst, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Kevin Lee Freeman has shown a selling trading pattern, with $0 in total purchases and $103.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin Lee Freeman was on Sep 1, 2023, when they sold $99.7K worth of HCAT shares. This transaction involved 8,460 shares at $11.78 per share.
Kevin Lee Freeman currently owns 358,686 shares of Health Catalyst, Inc. (HCAT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin Lee Freeman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin Lee Freeman has 17 Form 4 filings on record as an insider at Health Catalyst, Inc..
Set alerts for Kevin Lee Freeman and 40,000+ other insiders.